Investor Type

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
Institutional Investor Advisor Individual Investor

Richard Freeman

Managing Director, Portfolio Manager
41 Years experience
34 Years at ClearBridge

"A good aggressive growth company doesn't just seize new opportunities - it can also create them."

Richie co-manages the Aggressive Growth, Multi Cap Growth and All Cap Growth strategies and various Energy MLP Closed-End Funds. He is a member of the ClearBridge Investments Management Committee. He has been fascinated by the stock market since 1966, when at the age of 13 he would sit in a local brokerage firm after school and watch the ticker. Richie has 41 years of investment industry experience.

In 1983 Richie joined Shearson American Express, a predecessor organization, as co-manager of an aggressive growth mutual fund. He became a portfolio manager for ClearBridge Multi Cap Growth portfolios in 1991. His prior positions include vice president for trusts and investments at Chemical Bank and vice president of research at Drexel Burnham Lambert.

Richie received his BS in Accounting from Brooklyn College, and his MBA in Finance from New York University's Leonard N. Stern School of Business. Richie is a New York baseball enthusiast and enjoys playing golf in his spare time.


  • 41 years of investment industry experience
  • Joined a predecessor organization in 1983
  • Member of the ClearBridge Management Committee
  • Shearson American Express - Portfolio Manager of the Shearson Aggressive Growth Fund - 1983; Portfolio Manager of Mid/Small Capitalization Growth Portfolios - 1991
  • Chemical Bank - Vice President, Trusts and Investments
  • Drexel Burnham Lambert - Vice President, Research
  • MBA in Finance from New York University's Leonard N. Stern School of Business
  • BS in Accounting from Brooklyn College


  • Aggressive Growth Strategy
    April 2017 Commentary: The recent period of market consolidation could pave the way for another move higher.
  • All Cap Growth Strategy
    1Q17 Commentary: Technology and health care led a rebound for growth stocks.
  • Multi Cap Growth Strategy
    1Q17 Commentary: Receding correlations should heighten the impact of stock selection.
  • Aggressive Growth Strategy
    1Q17 Commentary: Cyclical technology stocks drove results in a strongly positive quarter.
  • Aggressive Growth Strategy
    February 2017 Commentary: Biopharmaceutical stocks drove performance for the month.
  • Aggressive Growth Strategy
    January 2017 Commentary: With major indexes trading near all-time highs, we believe active stock selection and sector allocation are at a premium.
  • All Cap Growth Strategy
    4Q16 Commentary: A post-election rally has placed a greater emphasis on stock and sector selection.
  • Multi Cap Growth Strategy
    4Q16 Commentary: The quarter closed a period of optimism that has lifted stocks broadly and tempered our outlook.